Publicação
Deal Trends in Alzheimer's Disease
IQVIA Pharma Deals
Dec 20, 2021
Neurological diseases, particularly conditions that come with a high social and financial burden, such as Alzheimer's disease, have attracted increasing levels of interest and investment as demonstrated by the rising number of deals by the biopharma industry. However, deal activity has fluctuated in recent years likely due to the low success rate of effective drugs reaching the market after key drug withdrawals and late-stage clinical disappointments.
Contact Us